You are here: All Products  > Jemincare Out-licenses Prostate Cancer Drug to Roche in $650 Million Deal

Jemincare Out-licenses Prostate Cancer Drug to Roche in $650 Million Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days. 


Back to products